The head of the IRS isn't even worrying about the results from the Supreme Court case subsidy ruling. And let's all reflect on the Aduro IPO - because it is kind of a big deal.
Traditional approaches to cancer are quite limited in treating late-stage and aggressive cancers. Aduro BioTech, Inc., a clinical-stage immunotherapy company, is using the immune system to fight cancer and provide more options for patients. The immune system defends against the growth and spread of tumors. Cancer develops as a result of multiple changes in the […]
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.